FDA Inspection
RxCrossroads 3PL LLCRxCrossroads 3PL LLC – FDA Inspection, May 9, 2023
Record Details
This FDA Inspection record concerns RxCrossroads 3PL LLC, with an inspection on May 9, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 07c4b553-2740-4197-80dd-b2ef5016811b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1204863
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.80(d)Status of Each Lot Identified
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.80(d)Status of Each Lot Identified
Full citation text and observation details available on the Dashboard.
Other FDA inspections of RxCrossroads 3PL LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 9, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 15, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 26, 2018 | Not classified | Cincinnati District Office |
Other documents for RxCrossroads 3PL LLC
- FDA Inspection 1322452 - 2026-06-09
- FDA Inspection 1084833 - 2018-11-15
- FDA Inspection 1072124 - 2018-10-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.